Jeffrey Albert
Director of Chemistry
Durg Development
Epigenetix
United States of America
Biography
Dr. Albert has a 20-year track record in the identification and validation of new drug targets, discovering initial chemical leads, and in advancing those leads through pre-clinical discovery to Phase-1. He served as Head of Lead Generation in Neuroscience Chemistry at AstraZeneca. He has authored or co-authored 4 book chapters, 32 scientific publications, filed more than 40 patents, and frequently lectures on drug discovery both in the United States and internationally.
Research Interest
Drug Discovery,Neuroscience Chemistry
